Tenax Therapeutics Inc NASDAQ:TENX:
TENAX THERAPEUTICS: EXTENDS US REGULATORY APPROVAL DEADLINE TO DECEMBER 31, 2035 VIA SIXTH AMENDMENT TO ORION LICENSE - SEC FILING
Reuters
Tenax Therapeutics Extends Us Regulatory Approval Deadline To December 31, 2035 Via Sixth Amendment To Orion License - SEC Filing
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NASDAQ:TENX
- Language
- English
Tenax Therapeutics Inc NASDAQ:TENX: